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In Situ Microscopy Analysis Reveals Local Innate Immune
Response Developed around Brucella Infected Cells in
Resistant and Susceptible Mice
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Abstract
Brucella are facultative intracellular bacteria that chronically infect humans and animals causing brucellosis. Brucella are able
to invade and replicate in a broad range of cell lines in vitro, however the cells supporting bacterial growth in vivo are largely
unknown. In order to identify these, we used a Brucella melitensis strain stably expressing mCherry fluorescent protein to
determine the phenotype of infected cells in spleen and liver, two major sites of B. melitensis growth in mice. In both tissues,
the majority of primary infected cells expressed the F4/80 myeloid marker. The peak of infection correlated with granuloma
development. These structures were mainly composed of CD11b+ F4/80+ MHC-II+ cells expressing iNOS/NOS2 enzyme. A
fraction of these cells also expressed CD11c marker and appeared similar to inflammatory dendritic cells (DCs). Analysis of
genetically deficient mice revealed that differentiation of iNOS+ inflammatory DC, granuloma formation and control of
bacterial growth were deeply affected by the absence of MyD88, IL-12p35 and IFN-c molecules. During chronic phase of
infection in susceptible mice, we identified a particular subset of DC expressing both CD11c and CD205, serving as a
reservoir for the bacteria. Taken together, our results describe the cellular nature of immune effectors involved during
Brucella infection and reveal a previously unappreciated role for DC subsets, both as effectors and reservoir cells, in the
pathogenesis of brucellosis.
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Introduction
Brucella (a-proteobacteria) are facultative intracellular Gram-
negative coccobacilli that infect humans as well as domestic
(goat, sheep, swine, etc.) and wild type mammals. Animal
infection leads to abortion and infertility with dramatic economic
costs. Brucellosis is mainly transmitted to humans through the
ingestion of raw milk or non-pasteurized cheese contaminated
with Brucella. It is characterized by undulant fever which, if left
untreated, can result in chronic disease with serious clinical
manifestations, such as orchitis, osteoarthritis, spondylitis, endo-
carditis, and several neurological disorders [1–5]. Human
brucellosis remains a significant public health concern in areas
of the world where Brucella infections are endemic in food
animals. Indeed, brucellosis has been described as being the most
common zoonotic disease worldwide with more than 500,000
new human cases annually [4].
Brucella are highly infectious via oral and aerosol routes and
difficult to treat with antibiotics. No safe or effective vaccine is
available to prevent human infection. These characteristics justify
the classification of Brucella strains as a category B pathogens,
which represent a risk for use as bioweapons [6],[7].
B. melitensis is the most frequent cause of human brucellosis
[1,8]. Recently, bioluminescent B. melitensis has been used to
visualize the dynamic of bacterial dissemination following
intraperitoneal (i.p.) inoculation in mice [9]. Results confirmed
that this model parallels human infection and identified major sites
of bacterial growth, such as the spleen and the liver, during the
early chronic phase of infection. However, cells supporting
bacterial growth in vivo in these organs and serving as reservoir
are unknown.
Despite recent progress in mouse models of brucellosis, much
remains unknown regarding cellular components of the innate and
adaptive immune responses induced by B. melitensis infection. We
PLoS Pathogens | www.plospathogens.org 1 March 2012 | Volume 8 | Issue 3 | e1002575
and others have shown that IFN-c-producing CD4+ T cells [10–
14] and inducible Nitric Oxide Synthase (iNOS/NOS2)-produc-
ing inflammatory dendritic cells (iNOS-DC) [10] are major
components of protective immune response against B. melitensis.
Activation of these cells involves Toll Like Receptor (TLR) 4 and
TLR9 coupled to MyD88 adaptor protein [10]. However, there is
little understanding on where these cells are localized in situ so they
can initiate cellular interactions to control infection. Several
experimental models of infection by intracellular bacteria such as
Mycobacteria tuberculosis [15] and Listeria monocytogenes [9,16] have
illustrated the importance of the granulomatous lesion in limiting
both tissue damage and bacterial dissemination. The granuloma-
tous lesion is an organized and dynamic structure implicating
activated monocytes surrounded by T cells and granulocytes. Its
formation involves an orchestrated production of chemokines and
cytokines and the upregulation of their cognate receptors along
with the expression of addressins, selectins and integrins.
Altogether, these elements coordinate the recruitment, migration
and retention of cells to and within the granuloma. Chronic
granulomatous inflammation has been reported in spleen and liver
from natural hosts, human and mice infected by Brucella bacteria
[17]. However, the importance of granulomas in the control of
Brucella growth, their cellular composition and the signalling
pathways implicated in their formation are largely unknown.
To address these issues, we developed a B. melitensis strain stably
expressing mCherry fluorescent protein (mCherry-Br). This novel
tool has allowed us to determine the phenotype of Brucella-targeted
cells and characterize the composition and the dynamic of
granuloma in the spleens and livers of infected mice. We observed
the formation of iNOS+ granuloma structures surrounding
infected cells and identified iNOS-DC (CD11b+ CD11c+ Ly-
6G2 MHC-II+ iNOS+) and activated monocytes (CD11b+
CD11c2 Ly-6G2 MHC-II+ iNOS+) as the major cell types
constituting granulomatous lesions in both tissues. In addition, we
observed that alteration of the MyD88/IL-12/IFN-c axis deeply
affects the cellular composition of granulomas, reducing their
ability to control bacterial dissemination and leading to replication
and persistence of the pathogen in distinct cellular niches.
Results
Construction of mCherry stably expressing Brucella
melitensis 16M
In order to detect infected cells on tissue sections by fluorescent
microscopy, we constructed a constitutively fluorescent strain of B.
melitensis. The mCherry protein, a previously described rapidly
maturing variant of the red fluorescent protein DsRed [18], was
cloned into the suicide vector pKSoriT-bla-kan downstream of a
strong Brucella spp. promoter PsojA [19,20]. The final construct was
transformed into Escherichia coli strain S17-1, and introduced into
B. melitensis strain by conjugation (see Material and Method for
details).
Flow cytometry (Figure S1.A) and fluorescent microscopy
(Figure S1.B) were used to validate mCherry-expressing Brucella
(mCherry-Br) strain in vitro. The comparison of wild type and
mCherry-Br strains growth curve revealed that mCherry gene
expression does not affect ability of B. melitensis to replicate in vitro
(data not shown). In addition, following i.p. inoculation of
46104 CFU, we showed that mCherry-Br was able to infect
chronically resistant C57BL/6 mice (Figure S1.C). At 5 days post
infection (p.i.), bacterial burden in spleen from mCherry-Br
infected mice was reduced by approximately half-a-log when
compared to wild type bacteria-infected mice. However, at 25 and
42 days p.i., bacterial counts from both groups were similar,
suggesting that bacterial virulence is moderately and transiently
affected by the insertion of mCherry tracer.
Detection of mCherry-expressing Brucella in tissues from
infected mice
In order to characterize the spatio-temporal behavior of Brucella
in spleen and liver of infected animals, we used immuno-
fluorescence microscopy techniques. At low dose of infection
(104 to 106 CFU) in C57BL/6 and BALB/c wild type mice,
growth of B. melitensis peaked at 5 days p.i. with modest CFU
counts (between 105–106 CFU/g of spleen [10]) rendering its
visualization on tissue sections very difficult. Our preliminary
studies demonstrated that 106 CFU/g of tissue was the limit of
sensitivity of our technique, with less than 0.1 infected cells by
observation surface (2006230 mm) in tissue sections of 5 mm in
thickness and using a 636 objective (data not shown). Therefore,
in order to maximize our chances of visualizing the dynamic
behavior of mCherry-Br in vivo several days after inoculation, we
injected 108 CFU of bacteria in wild type mice. With this dose, no
increase in mortality of mCherry-Br infected wild type C57BL/6
and BALB/c mice was observed (data not shown). Importantly,
when compared to the routinely used low bacterial inoculum, a
high infectious dose (108 CFU) showed similar impact on the
composition of recruited spleen cell populations involved in innate
inflammatory responses to Brucella. Overall, a high bacterial
inoculum only shorten the kinetic of cell recruitment (Figure S2).
First analyses revealed that ten minutes after i.p. inoculation,
bacteria were massively present in the spleen and the liver, with an
average of 106 CFU/g (Figure S3.A). Both organs maintained a
level of 106–108 CFU/g during the 5 first days p.i. (Figure S3.A),
allowing the analysis of mCherry-Br infected cells in situ during this
time (Figure S3.B). Infected susceptible BALB/c mice displayed
significantly higher count of bacteria in the spleen at 3 and 5 days
p.i. when compared to C57BL/6 mice. However, at day 12,
spleens and livers from wild type mice had less than 105–
106 CFU/g and bacteria became undetectable by microscopy
Author Summary
Brucella are facultative intracellular bacteria chronically
infecting humans and animals causing brucellosis, one of
the most common zoonotic disease worldwide which can
result in infertility and chronic debilitating disease. The
cells supporting Brucella growth in vivo remain largely
unknown. In order to identify these, we constructed a
Brucella melitensis strain expressing a fluorescent protein
that allowed us to characterize infected cells by micros-
copy of the spleen and liver from infected mice. In both
tissues, the majority of primary infected cells were cells
from the macrophage lineage. The peak of infection
correlated with granuloma development. These structures
contained the majority of bacteria and were mainly
composed of cells expressing CD11b, F4/80, MHC-II, which
are specific of activated monocytes/macrophages. A
fraction of granuloma cells also expressed CD11c and
were similar to inflammatory dendritic cells (DCs). During
the chronic phase of infection in susceptible mice, we
identified a particular subset of DC expressing CD205 and
serving as a reservoir for the bacteria. Overall, our results
describe the nature of immune cells infected by Brucella in
vivo and reveal an unappreciated role for DC subsets, both
as effectors and reservoir cells. These results could help
develop new therapeutic strategies to control Brucella
infection.
In Situ Identification of Brucella Infected Cells
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analysis (data not shown). Consequently, we limited our analysis to
120 h p.i. in wild type mice.
First Brucella-infected splenocytes are mainly F4/80+ red
pulp macrophages and MOMA-1+ metallophilic marginal
zone macrophages
The functions of the spleen are centered on systemic blood
circulation. As such, it lacks afferent lymphatic vessels. It is
comprised of two functionally and morphologically distinct
compartments, namely the red pulp (r.p.) and the white pulp
(w.p.). The r.p. is a blood filter rich in F4/80+ macrophages that
removes foreign material as well as damaged and effete
erythrocytes. The spleen is also the largest secondary lymphoid
organ of the body that initiates immune responses to blood-borne
antigens. This function is usually associated to the w.p.
compartment. This latter is centered on the central arteriole
within the T cell rich area surrounded by B lymphocyte-associated
follicles. At the interface between the r.p. and w.p., the marginal
zone (m.z.) is a unique region of the spleen. Considered to be a
separate compartment rather than part of the w.p., it is designed to
screen systemic blood circulation for antigens and pathogens and
plays an important role in antigen processing. It also contains
several populations of specialized macrophages, such as marginal
zone-associated metallophilic macrophages that can be identified
with anti-MOMA-1 antibody (for a review see [21]).
Following i.p. inoculation of 108 CFU in resistant wild type
C57BL/6 mice, mCherry-Br was detectable in the spleen by
10 minutes p.i. (Figure S3.A). Importantly, at this time, our
observation showed that mCherry-Br already localized in the r.p.
and the m.z. of infected spleens (data not shown). Then, bacteria
increased exponentially during the first 24 h (Figure S3.A) and the
number of intracellular bacteria peaked at 120 h p.i. with an
average of 8–10 bacteria per cell (Figure 1.A). Importantly,
infected cells were mainly located in m.z. and r.p. during the
whole kinetic of infection (Figure 1.B–C and Figure 2.A) while
infected cells were rarely observed in splenic w.p. area (w.p.).
Further semi-quantitative analyses of infected cell phenotypes in
C57BL/6 mice (Figure 2.B and Figure 3.A–B) showed that first
infected cells in spleen were mainly r.p. macrophages with a F4/
80+ CD11b2 phenotype (,80%) and MOMA-1+ m.z. metallo-
philic macrophages (,20%). Between 3 and 6 h after inoculation,
the frequency of infected MOMA-1+ cells decreased strongly and
CD11c+ dendritic cells progressively became infected (,30% of
total infected cells at 6 h) (Figure 3.A).
Using a home-made rabbit polyclonal antibody specific of B.
melitensis (Brucella-Ag), we showed that mCherry-Br fluorescence
and Brucella-Ag staining were generally overlapping (Figure S4),
although there were some instances where Brucella-Ag staining
could be detected in the absence of appreciable mCherry-Br
fluorescence, possibly as a consequence of bacterial death or
trafficking of antigens away from the bacteria. These results
confirm that the majority of Brucella-infected cells can be detected
in situ using mCherry-Br.
Confocal analysis in Z-stack demonstrated that bacteria
localized inside F4/80+ r.p. macrophages (Figure S5.A–B).
Importantly, this was also true for mCherry-expressing VirB-
defective Brucella mutant (Figure S5.C). The VirB mutant displays
a strongly reduced ability to infect cells in vitro [22] though it is able
to persist several days in vivo and colonize mice similarly to wild
type bacteria [23]. Therefore, it has been hypothesized that in vivo
persistence could be due to extracellular replication [24].
However, our observations are not in favor of this hypothesis
since VirB mutant and wild type bacteria both localized within
cells of the same phenotype in infected spleen at least in the first
72 h p.i. (data not shown). As expected, VirB mutant is no longer
detectable in situ at 120 h p.i.
Control of Brucella infection in the spleen is correlated to
the formation of F4/80+ MHC-II+ iNOS+ granulomas
Our analysis revealed that the phenotype of infected spleen cells
presented a drastic evolution between 24 h and 120 h p.i. Indeed,
at 24 h p.i., about 80% of infected cells were CD11b2 F4/80+ r.p.
macrophages (Figure 3.A–B), a fraction of which also expressed
MHC-II+ molecules (Figure 3.B and Figure 4.A). Between 24 h
and 72 h, the percentage of CD11b+ Ly-6G2-infected monocytes
increased progressively (Figure 3.B and Figure S6). At 120 h, these
monocytes constituted ,30–40% of the infected cell population
(Figure 3.B) and were mainly found clustered in granulomas (data
not Shown).
Granulomas were constituted of CD11b+ F4/80+ Ly-6G2
MHC-II+ cells surrounded by CD90+ cells (T cells) and Ly-6G+
cells (granulocytes) (Figure 3.A–B, Figure 4.B, Figure 5.A). A
fraction of CD11b+ F4/80+ MHC-II+ cells was also CD11c+
(Figure 5.A), suggesting that these cells were inflammatory DC. In
previous reports, these inflammatory DC were detected by flow
cytometry and identified as the main iNOS-producing cells during
Brucella infection [10]. In agreement with this finding, we observed
in situ that CD11b+ and CD11c+ cells located in granulomas were
iNOS+ (Figure 5.B) and co-localized with mCherry-Br signal.
Importantly, B cells (B220+ cells), T cells (CD90.2+ cells) or
granulocytes (Ly-6G+ cells) seemed very rarely infected during the
course of infection in the spleen (Figure 3.A–B and data not
shown). Of note, a weak expression of CD90.2 was detected on a
fraction of highly infected cells within granulomas (Figure 3.A).
These cells displayed a cellular morphology (large cells with
uncondensed nuclei) distinct from T lymphocytes and co-localized
with CD11b and F4/80 (data not shown), suggesting that they
were not lymphocytes but rather myeloid cells.
In summary, we concluded that infection seems largely limited
to a fraction of the myeloid cell compartment in the spleen. Since
the establishment of Brucella infection at day 5 in the spleen
correlated with monocytes recruitment and formation of granu-
lomas, we hypothesize that these latter are involved in bacterial
containment and/or elimination as these structures contain most
of the iNOS-producing cells. Granulomas were also detected in
r.p. area of spleen from C57BL/6 mice infected for 5 days with
46104 CFU (Figure S7.A). As expected, their numbers were
reduced when compared to mice infected with 108 CFU.
Surprisingly, at 12 days p.i. with both doses, granulomas were
mostly located in w.p. area, specifically in T cells zones (Figure
S7.A–B). Unfortunately, at this time point, we were not able to
determine the presence of Brucella since the bacterial load was
under our limit of detection. However, the similarity of the
phenotype of these structures (CD11b+ and F4/80+, Figure S7.A
and S7.B) with r.p. granulomas suggests that they may surround
rare infected cells.
Brucella infects similar cell phenotypes in resistant
C57BL/6 and susceptible BALB/c mice
It has been frequently reported that BALB/c mice display
higher bacterial loads per organs when compared to C57BL/6
mice during Brucella infection [10,25]. The reasons for this
susceptibility are unclear but it has been associated with lower
frequency of IFN-c-secreting CD4+ cells and iNOS-producing
cells in these mice [10]. In accordance with CFU counts measured
in spleens (Figure S3.A), the average number of bacteria per cell
observed by microscopy analysis in BALB/c and C57BL/6 mice
In Situ Identification of Brucella Infected Cells
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was similar at 48 h, though this number was slightly higher at
120 h in BALB/c mice (Figure 1.A). To determine whether
enhanced susceptibility of BALB/c mice could be associated with
the persistence of bacteria in distinct cell reservoirs, we further
examined the phenotype of infected cells in both mouse strains at
that time point. As observed for C57BL/6 mice, the large majority
of infected cells were mainly located in splenic r.p. and m.z. in
BALB/c mice (Figure 1.B–C) and semi-quantitative analyses of
infected cell phenotypes (Figure 3.C) showed a global similarity
between C57BL/6 and BALB/c mice. However, the frequency of
infected cells located in w.p. was higher in BALB/c mice when
compared to C57BL/6 mice (Figure 1.B–C). Further comparative
analysis (Figure 1.D–E) of the spatial distribution of infected spleen
cells showed that highly infected cells (.20 bacteria/cell) were
more frequent in BALB/c infected mice and located mainly in
w.p. areas.
In conclusion, infected cell phenotypes are relatively similar in
both mouse strains but higher colonization of w.p. cells in infected
BALB/c mice seems to explain for their higher CFU counts.
These cells frequently expressed MOMA-1 or CD11c markers but
were negative for CD11b, F4/80, Ly-6G and CD90.2 (data not
shown).
Brucella infection induces splenic dendritic cell migration
and maturation
Brucella have frequently been described as silent or stealthy
pathogens, able to actively escape the immune response through
their ability to grow furtively within cells [26]. This hypothesis is
mainly based on the fact that Brucella’s lipopolysaccharide (LPS) is
a weak activator of macrophages and DC by comparison to
conventional LPS from Escherichia coli [27]. In our study, we
observed that CD11c+ DC represent 10–30% of spleen cells
infected by mCherry-Br during the first 12 h of infection
(Figure 2.B and Figure 3.A). Therefore, in our experimental
conditions (108 CFU i.p.), we investigated the impact of Brucella
infection on DC activation in vivo in C57BL/6 mice. Imaging
Figure 1. Spatial distribution of infected cells in spleen of C57BL/6 and BALB/c mice. Wild-type C57BL/6 and BALB/c mice were injected
i.p. with PBS or 108 CFU of mCherry-Br. Mice were sacrificed at selected times and spleens were collected and examined by
immunohistofluorescence. A, The average number of bacteria per infected spleen cells at 48 h and 120 h p.i.. B, C, The percentage of infected
cells and bacteria localized in the r.p. and m.z., or w.p. at 120 h p.i.. D–E, The comparative analysis of the bacterial load per cell present in the r.p. and
m.z., or w.p.. For each conditions, a minimum of 200 cells has been examined. The bars are the mean6SD from at least 3 spleen sections per spleen
from 6 mice.
doi:10.1371/journal.ppat.1002575.g001
Figure 2. Red pulp localization of B. melitensis at the onset of infection. Wild-type C57BL/6 mice were injected i.p. with PBS or 108 CFU of
mCherry-Br. Mice were sacrificed at selected times and spleens were collected and examined by immunohistofluorescence. A, Positioning of
mCherry-Br in the spleen of mice at 3 and 24 h p.i. The inset areas in the middle panels are shown in the bottom panels. B, Immunoflurescence
analysis of F4/80, MOMA-1, Ly-6G, and CD11c expressing cells and mCherry-Br in the spleen of mice at 3 h p.i. Panels are color-coded with the text for
the antigen or mCherry-Br examined. Scale bar = 200 and 50 mm, as indicated. r.p.: red pulp; w.p.: white pulp; m.z.: marginal zone. Data are
representative of at least 3 independent experiments.
doi:10.1371/journal.ppat.1002575.g002
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analysis (Figure S8) of spleen sections revealed that 24 h post
inoculation, CD11chigh DCs relocated massively to w.p. T cell
area.
Flow cytometry analyses demonstrated that DC migration
observed in situ at 24 h p.i. was associated with their maturation as
shown by cell surface up-regulation of MHC-II and CD86 co-
stimulatory molecule expression on CD11chigh spleen cells (Figure
S9.A). Although we observed maturation of all splenic DC subsets
(CD82 and CD8+) (data not shown), we also found that direct
infection of DC was not required to trigger the phenomenon since
DC observed by microscopy in w.p. T cell area at 24 h p.i. were
not associated with mCherry-Br signal (data not shown). A lower
dose of bacteria (46104 CFU) was able to induce DC maturation
but the peak of maturation was reduced and displaced to 48 h p.i.
(data not shown). Importantly, administration of heat-killed (HK)
Brucella was also able to induce a dose-dependent DC maturation
(Figure S9.B), suggesting that Brucella’s pathogen-associated
molecular patterns (PAMPs) were sufficient to trigger this process.
By comparison, HK Escherichia coli induced DC maturation at a
ten-fold lower dose (Figure S9.B). Finally, using genetically
deficient C57BL/6 mice, we investigated the role of MyD88 and
TRIF adaptor molecules in DC maturation process in vivo and
found that MyD88, but not TRIF, was important to Brucella-
induced DC maturation (Figure S9.C).
Granuloma formation is observed in Brucella-infected
livers
Since the liver constitutes another important site of bacterial
growth, we investigated the phenotype of infected cells in this
organ in order to identify the common characteristics of infected
cells in immunological and non-immunological sites. At 10 min
p.i., mCherry-Br signal was already detectable in liver sections
Figure 3. Phenotypical characterization of B. melitensis infected cells in the spleen. Wild-type C57BL/6 and BALB/c mice were injected i.p.
with PBS or 108 CFU of mCherry-Br. Mice were sacrificed at selected times and spleens were collected and examined by immunohistofluorescence.
Data indicate the percentage of mCherry-Br that colocalizes with (A) CD90.2-, B220-, Ly6G-, MOMA-1-, F4/80-, CD11c-, (B) MHCII-, iNOS-, CD11b-
expressing cells at the selected time in C57BL/7 mice. (C) Comparison at 120 h p.i. between C57BL/6 and BALB/c mice. The bars are the mean6SD
from at least 3 spleen sections per spleen from 5 mice.
doi:10.1371/journal.ppat.1002575.g003
Figure 4. Characterization of F4/80+ infected cells in the spleen. Wild-type C57BL/6 mice were injected i.p. with PBS or 108 CFU of mCherry-
Br. Mice were sacrificed at selected times and spleens were collected and examined by immunohistofluorescence. A, Immunoflurescence analyses of
F4/80, MHC-II, and actin expression in spleen of mice at 24 h and 120 h after mCherry-Br infection. Yellow circles and arrowheads indicate the
presence of the bacterium. Panels are color-coded with the text for the antigen or mCherry-Br examined as well as the colocalization. B,
Colocalization analysis of F4/802 and MHCII-expressing cells in spleen of mice before and 120 h after mCherry-Br infection. Scale bar = 50 and
200 mm, as indicated. r.p.: red pulp; w.p.: white pulp, m.z.: marginal zone. Data are representative of at least 3 independent experiments.
doi:10.1371/journal.ppat.1002575.g004
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from infected C57BL/6 and BALB/c wild type mice and co-
localized strictly with F4/80+ MHC-II+ Kupffer cells (data not
shown). At 120 h post-inoculation, microscopy analyses revealed
that, as observed in the spleen, the liver also displayed numerous
granulomas composed of F4/80+ MHC-II+ CD11b+ cells (Figure
S10). Granulomas frequently surrounded portal space and
harbored the majority of infected cells (data not shown). As it
was the case in the spleen, iNOS expression was mainly associated
with a fraction of granuloma cells expressing CD11c, suggesting
that activated monocytes and inflammatory DC were also major
populations of these structures. Importantly, we never observed
bacteria inside hepatocytes or Ly-6G+ granulocytes suggesting
that, like in the spleen, infection is limited to a specific fraction of
the myeloid cell compartment.
Formation of granuloma is partially independent on
adaptive immunity
As granulomas seem to be the main organized cellular
structures containing Brucella in the spleen and the liver, we tried
to define the role of T and B lymphocytes in their formation. We
infected RAG deficient C57BL/6 mice with 108 CFU of
mCherry-Br. RAG2/2 mice displayed higher CFU counts in the
spleen, but not in the liver, at 120 h p.i. (Figure S11). At the same
time, microscopy analysis of tissue sections showed that absence of
T and B lymphocytes did not impair F4/80+ CD11b+ CD11c+
iNOS+ granuloma formation in either tissues (Figure 6). Flow
cytometry analyses confirmed that recruitment of iNOS-DC was
not compromised in the spleen of RAG2/2 infected mice (Figure
S12). However, in RAG2/2 infected spleens, granulomas seemed
less organized and less dense. In addition, higher numbers of
iNOS+ cells and infected cells were observed outside of
granulomas and frequency of F4/802 infected cells was higher
when compared to wild type mice (Figure 6). These latter
observations could be correlated with the presence of Ly-6G+
infected cells in the spleen of RAG2/2 mice (data not shown).
MyD88, IL-12 and IFNc are required for granuloma
formation
In order to gain insight into immune mechanisms controlling
bacterial growth in the spleen, we used a genetic approach to
investigate the impact of MyD88, IL-12p35 and IFN-c
deficiencies on the phenotype of infected cells with a particular
focus on the ability of the immune response to establish
granulomas. These molecules have been described as key elements
of Th1-driven immune response controlling Brucella growth in vivo
[10],[14,28],[12]. In agreement with previous published results, all
Figure 5. Phenotypical description of B. melitensis infected granulomas in the spleen. Wild-type C57BL/6 mice were injected i.p. with PBS
or 108 CFU of mCherry-Br. Mice were sacrificed at 120 h p.i. and spleens were collected and examined by immunohistofluorescence. A,
Immunofluorescence analysis of Ly-6G, CD90.2, CD11b, CD11c, F4/80, and MHC-II expressing cells and mCherry-Br. B, Percentage of iNOS+ cells that
colocalize with CD11b-, and CD11c-expressing cells. Numbers in B indicate the percentage of colocalizing cells in the upper panel. Images represent a
single granuloma. Panels are color-coded with the text for the antigen or mCherry-Br examined as well as the colocalization. Scale bar = 50 mm, as
indicated. Data are representative of at least 3 independent experiments.
doi:10.1371/journal.ppat.1002575.g005
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deficient mice displayed higher CFU counts in spleen and liver at
120 h p.i. (Figure S11). As expected, frequencies of IFN-c+ cells
and iNOS-DC in infected spleen were drastically reduced in all
Th1 deficient mice when compared to infected wild type mice
(data not shown and Figure S12).
Immunofluorescence analysis of liver and spleen sections from
120 h-infected mice showed that all three deficient mouse strains
displayed dense aggregates of CD11b+ cells surrounding infected
cells and resembling granulomas (Figure 7 for spleen and liver
from wild type and MyD882/2 mice and data not shown for IL-
122/2 and IFN-c2/2 mice). Whereas iNOS staining was strongly
reduced in all three deficient mouse strains (Figure 7 and data not
shown), CD90.2+ T cells recruitment around infected cells was
normal (data not shown). Moreover, granuloma-like structures in
all deficient mouse strains frequently contained higher numbers of
infected Ly-6G+ cells but reduced density of F4/80+ and CD11c+
cells (Figure 8 for liver granulomas and data not shown for spleen
granulomas). These ‘‘unconventional’’ granulomas, characterized
by an inverted ratio of granulocytes versus monocytes/DC, failed
to control bacterial growth as demonstrated by an increased
mCherry-Br signal in deficient mice, with higher numbers of
infected cells outside of granuloma like structures. These
‘‘unconventional’’ granulomas were also detected in infected wild
type mice but at a low frequency.
Major cellular reservoir for Brucella in spleens of
chronically infected susceptible mice localizes in white
pulp and expresses MOMA-1 or CD11c and CD205
markers
One of our initial objectives was to characterize the phenotype
of Brucella reservoir cell types in chronically infected mice.
Unfortunately, the detection threshold of mCherry-Br signal in
situ required approximately 106 CFU/g of tissue (Figure S3.A and
B). Wild type mice initially infected with 108 bacteria displayed
CFU counts in spleen and liver inferior to this threshold at 12 days
p.i. and MyD882/2, IL-122/2 or IFN-c2/2 mice showed high
mortality rate at the same time point. Thus, in order to increase
the lifespan of genetically deficient mice, we tested an inoculum
dose of 106 CFU and compared bacterial loads in spleen and liver
at 5, 12 and 30 days p.i. (Figure S13). Only IL-12p402/2 BALB/c
mice displayed CFU counts superior to the detection threshold in
Figure 6. Phenotypical analysis of granuloma in the liver and spleen of wild type and RAG-deficient infected mice. Localization by
immunohistofluorescence of (A) F4/80, (B) CD11b, (C) CD11c and iNOS expressing cells in liver and spleen from 120 h mCherry-Br infected wild-type
and RAG2/2 C57BL/6. Mice were injected i.p. with 108 CFU of mCherry-Br. Images represent a single granuloma. Panels are color-coded with the text
for the antigen or mCherry-Br examined. Scale bar = 50 mm, as indicated. Data are representative of at least 3 independent experiments.
doi:10.1371/journal.ppat.1002575.g006
In Situ Identification of Brucella Infected Cells
PLoS Pathogens | www.plospathogens.org 9 March 2012 | Volume 8 | Issue 3 | e1002575
spleens at 12 and 30 days p.i. Interestingly, microscopy analysis of
tissue sections from spleens from infected IL-122/2 BALB/c mice
(Figure S14.B) showed that mCherry-Br signal, initially located in
r.p. at 12 h p.i., progressively relocated in w.p. at 5, 12 and 30
days p.i. This preferential localization in w.p. was also observed in
infected IL-122/2 C57BL/6 at 5 days p.i. (Figure S14.C),
Figure 7. CD11b+ granulomas in the spleen and liver of wild type and MyD88-deficient infected mice. Mice were injected i.p. with PBS
(control) or 108 CFU of mCherry-Br. The figure presents the localization by immunohistofluorescence of CD11bhi and iNOS expressing cells in spleen
(A) and liver (B) from control and 120 h mCherry-Br infected wild-type and MyD882/2 C57BL/6. Panels are color-coded with the text for the antigen
or mCherry-Br examined. Scale bar = 200 mm, as indicated. r.p.: red pulp; w.p.: white pulp. Data are representative of at least 3 independent
experiments.
doi:10.1371/journal.ppat.1002575.g007
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demonstrating that the BALB/c background is dispensable to
observe this phenomenon. Surprisingly, the phenotype of Brucella-
containing cells located in w.p. of 12 days-infected IL-122/2
BALB/c mice was strikingly distinct from r.p. infected cells
previously described in wild type mice (Figure 9.A and 9.B).
Indeed, these cells were highly infected (.20 bacteria/cell) and
harbored two distinct cell surface marker combinations. When
localized in close proximity of m.z. area, the infected cells
expressed MOMA-1, a specific marker of metallophilic marginal
zone macrophages, whereas when located deeply within the w.p.,
they expressed CD11c and DEC205/CD205 (Figure 9.B), both
DC-specific molecules. Both types of cells were negative for iNOS,
F4/80, CD11b, CD86, CD90.2 and B220 (data not shown) and a
fraction of them expressed weakly MHC-II. Although the bacterial
load was reduced, the phenotype and location of IL-122/2
infected cells was similar 30 days p.i., (data not shown).
Interestingly, highly infected CD11c+ cells located in the w.p. of
wild-type BALB/c mice could also be observed 5 days p.i. but at a
very low frequency (Figure 9.C and data not shown) suggesting
that those cells are not limited to Il-122/2 BALB/c mice.
Given that these heavily infected w.p. cells were not found
associated with CD11b+ F4/80+ iNOS+ effector cells, we conclude
that they may constitute an important reservoir for B. melitensis
under permissive conditions such as absence of Th1 protective
response.
Discussion
Bacteria of the genus Brucella, have been long studied as a
relevant experimental model to analyze chronic infections of
animals and humans due to the great impact they have on both
husbandry practice and human health worldwide [29]. Their
virulence and the chronicity of the ensuing disease rely on their
ability to modulate both innate and adaptive immune responses
and the physiology of the host’s cells in which they reside, survive
and multiply (reviewed in [30]).
The mouse is considered as a useful animal model to investigate
the pathogenesis of brucellosis, to identify specific virulence factors
of Brucella spp and to characterize the host immune response [29].
If classical studies [31,32], and more recently the use of genetically
deficient mice, have been useful to uncover the great avenues of
protective immune responses against Brucella infection [33], this
approach appears insufficient to dissect immune effector mecha-
nisms elaborated by the host to fight B. melitensis. Like Mycobacterium
tuberculosis [34,35],[36], and in contrast to other intracellular
bacteria such as Listeria monocytogenes [37] or Legionella pneumophila
[38], B. melitensis does not irreversibly affect the health status of the
majority of mice genetically deficient for key element of Th1
protective immune response (such as MyD88 [10],[39], IL-12p40
[11], IFN-c [12] and iNOS [11]) during the first four weeks of
infection. These observations suggest that immune effector
mechanisms against Brucella are multiple and redundant, and
necessitate new approaches to be further characterized. This is the
perspective from which we decided to use in situ microscopy
techniques for studying the local immune response developed
around B. melitensis infected cells. Up to now, only gross
morphometric and histopathologic analyses have been conducted
[40–42] on spleen and liver, that are important sites for
colonization and replication of Brucella in the mouse model [29].
Both organs develop the so called ‘‘histiocytic infiltrates and
microgranulomas’’ [41,42]. Of importance, Brucella infection in
mice results in lesions mimicking those described in chronic
infections in humans which may also develop splenomegaly and
hepatomegaly [17,43]. To our knowledge, our study and the
recent work from Archambaud, C et al. [44] are the first in vivo
investigations characterizing the in vivo phenotype of Brucella-
infected cells. Archambaud, C et al. have focused their study on
Brucella abortus-infected pulmonary tissues following intranasal
inoculation. In contrast, we used an i.p. systemic model of
infection in order to analyse the phenotype of Brucella melitensis-
infected cells in spleen and liver. The i.p. route of infection is
generally used to establish a persistent infection in the mouse
because it leads to a rapid systemic distribution of Brucella sp. and
to high bacterial loads in both spleen and liver [33,45].
Brucella has been initially described as an intracellular bacteria
able to replicate in professional phagocytes such as macrophages
[46], DC [47] and granulocytes as well as non-professional
phagocytes [48], including epithelial, fibroblastic and trophoblastic
cells, in the context of cell line cultures. However, the identity of
Brucella reservoir cell types during the course of infection in vivo is
largely uncharacterized. If macrophages [40] and trophoblastic
cells [49] have been clearly associated with Brucella infection in the
natural hosts, little has been demonstrated regarding the
contribution of other potential cellular niches for Brucella in vivo.
In this study, using a Brucella strain stably expressing mCherry,
we demonstrated for the first time that these bacteria present a
very restrictive cellular tropism as the majority of infected cells in
the spleen and the liver of resistant C57BL/6 wild type mice
belongs to a specific fraction of the myeloid lineage. Granulocytes,
B cells, T cells, fibroblasts and hepatocytes were never found
significantly infected. This result may explain the frequent
discrepancies between in vitro and in vivo attenuation of various
Brucella mutants. In the physiological cell reservoir and in the
complex microenvironment of the host, some of the ‘‘virulence
factors’’ identified in vitro may have little or no relevance. A striking
example is the mutation affecting the gene virB which encodes the
type IV secretion system of Brucella. The virB mutant is unable to
grow within host cells in vitro [22] though it can replicate at a
similar level as the wild type strain during the first 5 days of
infection in vivo [23]. In the present study, virB mutant and wild
type bacteria were localized within the same cells in infected spleen
at all time-points analyzed during the first three days of infection.
This argues in favor of the intracellular localization of virB mutant
in vivo and strongly suggests that the type IV secretion system of
Brucella is tightly regulated during the infectious process. Since we
showed that the nature of the infected cells varied in a time-
dependent manner during the first days of infection, it is tempting
to speculate that the type IV secretion system depends on the
nature of the infected cells and/or its activation status.
Our study also brought to light the complexity and the dynamic
of the cellular environment of the pathogen during the course of
infection. In the spleen, m.z. (MOMA-1+) and r.p. (F4/80+)
macrophages are the first infected cells, followed by DCs (CD11c+)
located in m.z. and r.p.. We hypothesized that infection-mediated
inflammation is responsible of subsequent recruitment of CD11b+
Ly-6G2 monocytes. Our data suggest that these cells are rapidly
Figure 8. Phenotypical analysis of granuloma in the liver of wild type and MyD88-deficient infected mice. Colocalization by
immunohistofluorescence of CD11c (A), F4/80 (B), Ly-6G (C) and iNOS expressing cells with mCherry-Br signal in liver from 120 h mCherry-Br infected
wild-type and MyD882/2 C57BL/6. Mice were injected i.p. with 108 CFU of mCherry-Br. Panels are color-coded with the text for the antigen or
mCherry-Br examined. Scale bar = 50 mm, as indicated. Data are representative of at least 3 independent experiments.
doi:10.1371/journal.ppat.1002575.g008
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infected and progressively mature to form complex granulomas in
r.p. composed of a mix of activated mature monocytes (CD11b+
CD11c2 F4/80+ MHC-II+) and inflammatory DC (CD11b+
CD11c+ F4/80+ MHC-II+) and surrounded by T cells (CD90.2+)
and granulocytes (CD11b+ Ly-6G+). This scenario yields major
differences when compared with the observations by Archambaud
Figure 9. B. melitenis infects CD11c+ CD205+ or MOMA-1+ cells in spleens of chronically infected Il-12-deficient BALB/c mice. Wild-
type and Il-12p402/2 BALB/c mice were injected i.p. with PBS or mCherry-Br, as indicated. Mice were sacrificed 5 or 12 days p.i. and spleens were
collected and examined by immunohistofluorescence. A & B, Colocalisation of mCherry-Br with MOMA-1, CD11c, CD205 expressing cells in the spleen
of IL-122/2 BALB/c mice infected with 106 CFU 12 days p.i.. C, Higher magnification view of CD11c-expressing cells and mCherry-Br in w.p. of wild
type BALB/c mice infected with 108 CFU 5 days p.i.. Panels are color-coded with the text for the antigen or mCherry-Br examined as well as the
colocalization. Scale bar = 200 and 50 mm, as indicated. r.p.: red pulp; w.p.: white pulp, m.z.: marginal zone. Data are representative of at least 3
independent experiments.
doi:10.1371/journal.ppat.1002575.g009
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et al. [44] in the context of intra-nasal infection with Brucella
abortus. Although macrophages are the first infected cells in spleen,
liver, as shown in our study, and lungs [44], DC infection and
granulomas formation are not observed in lungs but only in
draining lymph node [44]. These discrepancies could be due to
differences in dose of infection, route of inoculation and bacterial
strain used in both studies.
It has been frequently reported that BALB/c mice display
higher bacterial loads per organ when compared to C57BL/6
mice during Brucella infection [10,25]. The reasons of this
susceptibility are unclear. In our experimental model, spleen and
liver infected cells displayed a closely similar phenotype and
localization. However, higher CFU counts observed in infected
BALB/c mice was related to increase colonization of w.p. cells.
These latter displayed high number of bacteria and expressed
MOMA-1 or CD11c markers but were negative for CD11b, F4/
80, Ly-6G and CD90.2,
Transient infection of CD11c+ cells during the early stages of
infection in the spleen leads us to characterize the impact of
Brucella infection on the maturation of conventional DC. Flow
cytometry and in situ staining showed that spleen infection with B.
melitensis induced the massive migration of DC in the T cell area of
w.p. as well as their maturation during the first 24 h of infection,
followed later, by their gradual disappearance. The relationship
between Brucella and DCs seems complex and necessitates further
experiments to be elucidated. However, our results demonstrate
clearly that the course of Brucella infection is associated to DCs
activation in spleen. This maturation is dependent of MyD88
adapter molecule and does not require infection as heat killed
Brucella induce a similar phenomenon. Importantly, microscopy
analysis indicated that none of CD11c+ mature cells migrating to
T cell area were infected by B. melitensis (data not shown),
suggesting that infection of DCs could impair their migration and
maybe their maturation. Again, these results are in agreement with
the stealthy strategy [30] attributed to Brucella and with in vitro
studies [50],[51] demonstrating the ability of Brucella to regulate
DC maturation.
Using genetically deficient mice, we partially clarified some
requirements for granuloma formation during Brucella infection.
Development of a Th1 response seems a critical step as MyD882/
2, IL-12p352/2 and IFN-c2/2 mice displayed iNOS2 altered
granulomas, strongly enriched in granulocytes. In contrast, the
analysis of RAG2/2 infected mice demonstrated that granuloma
formation at 5 days p.i. is, for a large part, independent of
lymphocytes. We hypothesized, in accordance with the granuloma
formation model proposed for Listeria monocytogenes infection [16],
that IFN-c is needed for maturation of monocytes in iNOS-DC
and building of fully functional granuloma. As previously
described [10], IFN-c was produced by Natural Killer (NK) cells
and T lymphocytes during Brucella infection. In RAG2/2 mice,
iNOS-producing DC (iNOS-DC) were detectable by flow
cytometry and microscopy analysis suggesting that absence of
IFN-c-producing T lymphocyte might be compensated by IFN-c-
producing NK cells. This was confirmed by the absence of iNOS-
DC in spleens of RAGcc2/2 (deficient for natural killer cells)
infected mice (data not shown).
The presence of phenotypically similar granulomas in the infected
spleen and liver support the hypothesis that granulomas constitute
the ‘‘spearhead’’ of the immune response against Brucella. Correla-
tion between high susceptibility of MyD882/2, IL-122/2 and IFN-
c2/2 mice and strongly altered granuloma structures in these mice
suggested a causal link between the presence of granulomas and
Brucella growth control. However, the precise role of granuloma
during Brucella infection remains to be clarified.
A prominent characteristic of Brucella is its capacity to persist in
natural host for life (reviewed in [30]). This property is thought to
be related to its capacity to (i) locate intracellularly and avoid the
fusion of Brucella-containing vacuoles with host cell lysosomes (ii)
limit or modulate the activation of innate and adaptive immune
response (mainly due to poorly recognized PAMPs of its cell
envelope and poorly characterized secreted effectors), (iii) prolong
the lifespan of infected cells. The previously unappreciated
restricted specificity of Brucella cell tropism that we observed in
vivo allows us to hypothesize that the ability of Brucella to persist
could also depend of its capacity to infect cell subsets particularly
adapted to sustain its growth and persistence. In absence of Th1
response, granuloma formation was altered and the bacterial
burden was significantly higher in spleens of IL-12p402/2 BALB/
c mice, making possible microscopy observation in situ and
characterization of infected cells during chronic phase of infection
(12 and 30 days p.i.). Our analyses revealed that the main infected
spleen cells at these time-points are located in the w.p. and express
the following cell surface phenotype: CD11b2 CD11c+ CD902
CD205+ F4/802 Ly-6G2 MHC-IIlow B2202 iNOS2. High
expression of CD11c and CD205 suggested that these cells are a
particular subset of DC. This phenotype is also partially
reminiscent of foamy macrophages that express high levels of
CD11c, CD205 and low level of MHC-II [52] and constitute
nutrient-rich reservoirs in lung granulomas of M. tuberculosis-
infected mice [53]. Interestingly, these cells were also detected,
albeit with a low frequency, five days post-infection in the w.p. of
wild type BALB/c mice infected with 108 CFU. Previously, we
demonstrated the reduced ability of BALB/c mice to mount Th1
[10] response in the context of Brucella melitensis infection. Thus,
permissive environments, such as the absence of Th1 response,
may drive the differentiation of macrophages toward a long-lived
and anti-inflammatory phenotype allowing bacterial persistence.
Identification of these cells as potential reservoir for Brucella in
chronically infected mice could help to ameliorate therapeutic
treatment of brucellosis.
In conclusion, this work dissected for the first time the nature of
the effectors mechanisms developed in vivo by the immune system
after B. melitensis systemic inoculation and described the pheno-
typic characteristics of infected cells during the initial and chronic
steps of the infectious process. These results could help develop
new strategies to control Brucella infection.
Materials and Methods
Ethics statement
The animal handling and procedures of this study were in
accordance with the current European legislation (directive 86/
609/EEC) and in agreement with the corresponding Belgian law
‘‘Arreˆte´ royal relatif a` la protection des animaux d’expe´rience du 6 avril 2010
publie´ le 14 mai 2010’’. The complete protocol was reviewed and
approved by the Animal Welfare Committee of the Faculte´s
Universitaires Notre-Dame de la Paix (FUNDP, Belgium)(Permit
Number: 05-558).
Mice and reagents
Genetically deficient mice in C57BL/6 background: MyD882/
2 [54] were obtained from Dr. S. Akira (Osaka University, Japan).
TRIF2/2 mice [55] were a kind gift from Dr. B. Beutler (The
Scripps Research Institute, CA), IL-12p352/2 mice [56] from Dr.
B. Ryffel (University of Orleans, France), IFN-c2/2 mice [57]
from Dr. S. Magez (Vrije Universiteit Brussel, Belgium), RAG12/
2 mice [58] from Dr. S. Goriely (Universite´ Libre de Bruxelles,
Belgium), RAGcc2/2 mice from Dr. Michel Y. Braun (Universite´
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Libre de Bruxelles, Belgium). IL-12p402/2 BALB/c mice were
obtained from Dr. V. Flamand (Universite´ Libre de Bruxelles,
Belgium). Wild type C57BL/6 mice and BALB/c mice purchased
from Harlan (Bicester, UK) were used as control. All mice used in
this study were bred in the animal facility of campus Gosselies
from the Free University of Brussels (ULB, Belgium).
B. melitensis strain 16M (Biotype1, ATCC 23456) was isolated
from an infected goat and grown in biosafety level III laboratory
facility. Overnight culture grown with shaking at 37uC in 2YT
media (Luria-Bertani broth with double quantity of yeast extract)
to stationary phase was washed twice in PBS (35006g, 10 min.)
before use in mice inoculation.
Construction of a mCherry-producing B. melitensis strain
The mCherry protein, a previously described rapidly maturing
variant of the red fluorescent protein DsRed [18], was cloned into
the suicide vector pKSoriT-bla-kan downstream a strong Brucella
spp. promoter [19,20], *nouvelle ref* Ko¨hler S, Infect Immun.
1999) previously used to express constitutively the GFP. This
promoter was called PsojA and described as controlling the
expression of the protein translocase SecE (Ko¨hler S.; personal
communication).
The vector was constructed as follows: the mCherry coding
sequence was amplified by PCR from pRSET-B-mCherry [18]
with the mCherry-up and -down primers and ligated into
pGemT-Easy (Promega) to generate pGEM-T-mCherry. The
mCherry fragment was then excised from pGEM-T-mCherry by
HindIII/XbaI double restriction and subsequently cloned into
HindIII/XbaI-cut pKSoriT-bla (pBluescript II KS vector from
Stratagene in which RP4 oriT was inserted in order to make this
vector mobilizable [59]) to generate pKSoriT-bla-mCherry.
Meanwhile, a 500 bp fragment upstream the coding sequence
of secE was amplified from the B. melitensis genome by PCR with
the PsojA-up and PsojA-down primers and ligated into pGemT-
Easy (Promega) to generate pGEM-T-SojA. The PsojA fragment
was then excised from pGEM-T-PsojA by NotI/XbaI double
restriction and subsequently inserted into NotI/XbaI-cut
pKSoriT-bla-mCherry to generate pKSoriT-bla-PsojA-mCherry. Fi-
nally, the aphA4 cassette (a promoterless kanamycin resistance
gene [60] was excised from pUC4aphA4 with SalI, and
subsequently cloned into the XhoI site of pKSoriT-bla-PsojA-
mCherry to generate plasmid pKSoriT-bla-kan-PsojA-mCherry. This
final construct was transformed into E. coli strain S17-1, and
introduced into B. melitensis 16M NalR strain by conjugation.
Clones that were kanamycin resistant and fluorescent were
further checked by PCR, confirming the insertion of the plasmid
at the targeted chromosomal PsojA promoter. Primers used in this
study (Sequence (59-39)): mCherry-up (XbaI) tctagaatggtgag-
caagggcgag, mCherry-down (HindIII) aagcttttacttgtacagctcgtcca,
PsojA-up (NotI) gcggccgccttgactatggatgcccgtt, PsojA-down (XbaI)
tctagactctgtctgatcaggcacaa.
Similar protocol has been used to construct mCherry-expressing
DVirB B. melitenis. Construction of DVirB mutant has been
previously described [61].
Mouse infection
Mice were injected intra-peritoneally (i.p.) with indicated dose
of B. melitensis in 500 ml of PBS. Control animals were injected with
the same volume of PBS. Infectious doses were validated by
plating serial dilutions of inoculums. At selected time intervals,
mice were sacrificed by cervical dislocation. Immediately after
being killed, spleen and liver were collected for bacterial count and
flow cytometry and microscopy analyses.
Bacterial count
For bacterial count, spleens and livers were recovered in PBS/
0.1% X-100 triton (Sigma). We performed successive serial
dilutions in PBS to get the most accurate bacterial count and we
plated them onto 2YT media plates. CFU were counted after 3
days of culture at 37uC.
Cytofluorometry analysis
Spleen were harvested, cut in very small pieces and incubated
with a cocktail of DNAse I fraction IX (Sigma-Aldrich Chimie
SARL, Lyon, France) (100 mg/ml) and 1.6 mg/ml of collagenase
(400 Mandl U/ml) at 37uC for 30 min. After washing, spleen cells
were filtered and incubated in saturating doses of purified 2.4G2
(anti-mouse Fc receptor, ATCC) in 200 ml PBS 0.5% BSA 0.02%
NaN3 (FACS buffer) for 10 minutes on ice to prevent antibody
binding to Fc receptor. 3–56106 cells were stained on ice with
various fluorescent mAbs combinations in FACS buffer and
further collected on a FACScalibur cytofluorometer (Becton
Dickinson, BD). We purchased the following mAbs from BD
Biosciences: Fluoresceine (FITC)-coupled 145-2C11 (anti-CD3e),
53-8.7 (anti-CD8e), M1/70 (anti-CD11b), GL-1 (anti-CD86),
Phycoerythrin (PE)-coupled HL3 (anti-CD11c), RM4-5 (anti-
CD4). Allophycocyanin (APC)-coupled M5/114.15.2 (anti-IA/
IE). The cells were analyzed on a FACScalibur cytofluorometer.
Cells were gated according to size and scatter to eliminate dead
cells and debris from analysis.
Intracellular cytokine staining
Spleen cells were treated as previously described [62]. Spleen
cells were incubated for 4 h in RPMI 1640 5% FCS with 1 ml/ml
Golgi Plug (BD Pharmingen) at 37uC, 5% CO2. The cells were
washed with FACS buffer and stained for cell surface markers
before fixation in PBS/1% PFA for 15–20 min on ice. These cells
were then permeabilized for 30 min using a saponin-based buffer
(16 Perm/Wash, BD Pharmingen in FACS buffer) and stained
with one or a combination of the following intracellular mAbs:
allophycocyanin-coupled XMG1.2 (anti-IFN-c; BD Biosciences),
purified M-19 (rabbit polyclonal igG anti-NOS2; Santa Cruz
Biotechnology) stained with Alexa Fluor 647 goat anti-rabbit
(Molecular Probes). After final fixation in PBS/1% PFA, cells were
analyzed on a FACScalibur cytofluorometer. No signal was
detectable with control isotypes.
Immunofluorescence microscopy
Spleens and livers were fixed for 6 h at 4uC in 2%
paraformaldehyde (pH 7.4), washed in PBS, incubated overnight
at 4uC in a 20% PBS-sucrose solution under agitation, and washed
again in PBS. Tissues were embedded in the Tissue-Tek OCT
compound (Sakura), frozen, in liquid nitrogen, and cryostat
sections (5 mm) were prepared. Tissues sections were rehydrated in
PBS, then incubated successively in a PBS solution containing 1%
blocking reagent (Boeringer) (PBS-BR 1%) and in PBS-BR 1%
containing any of the following mAbs or reagents: DAPI nucleic
acid stain, Alexa Fluor 350 or 488 phalloidin (Molecular Probes),
purified 1A8 (anti-Ly-6G), or rabbit polyclonal antibodies anti-
NOS2 (Calbiochem) (note that M-19 anti-NOS2; used for
cytofluorometry analysis is not use for immunofluorescence
microscopy), biotin-coupled HL3 (anti-CD11c, BD Biosciences),
NLDC-145 (anti-DEC205/CD205, BMA Biomedical AG),
MOMA-1 (anti Marginal Zone Macrophages, BMA Biomedicals),
53-2.1 (anti-CD90.2, BD Biosciences), RA3-6B2 (anti-CD45R/
B220, BD Biosciences), Alexa Fluor 647-coupled BM8 (anti-F4/
80, Abcam) M1/70 (anti-CD11b, BD Biosciences), M5/114.15.2
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(anti-IA/IE, eBiosciences). Uncoupled 1A8 mAb and anti-NOS2
polyclonal antibodies were detected using biotin-coupled R67/
1.30 (mouse anti-rat IgG2a, BD Biosciences) and Alexa Fluor 647-
coupled goat anti-rabbit IgG (Molecular Probes) in PBS-BR 1%,
respectively. Biotin-coupled mAbs were amplified using Alexa
Fluor 350 or Alexa Fluor 647 Streptavidin (Molecular Probes) in
PBS-BR 1%. Slides were mounted in Fluoro-Gel medium
(Electron Microscopy Sciences, Hatfield, PA). Labeled tissues
sections were visualized with an Axiovert M200 inverted
microscope (Zeiss, Iena, Germany) equipped with high resolution
monochrome camera (AxioCam HR, Zeiss). Images, 138461036
pixels (0.16 mm/pixel), were acquired sequentially for each
fluorochrome with A-Plan 106/0.25 N.A. and LD-Plan-NeoFluar
636/0.75 N.A. dry objectives and recorded as eight bit grey levels
*.zvi files. Colocalization between two stainings was analyzed using
the AxioVision Colocalization module (Zeiss). Double positive
pixels were rendered in white, gray or yellow as indicated in the
Figures. Images were exported as TIFF files and figures prepared
in Canvas 7 program.
For the estimation of the number of bacteria by cells or for the
phenotype of infected cells, a minimum of 200 cells by condition
were examined. These cells were counted in 6 mice minimum, in
two independent experiments. When the number of bacteria by
individual cell was too high to be determined, the number of
bacteria was assumed to be of 20 or more (see Figure 1.E).
Confocal analysis
Confocal analysis were performed with LSM510 NLO
multiphoton confocal microscope fitted on an Axiovert M200
inverted microscope equipped with C-Apochromat 406/1.2 N.A.
water immersion objectives (Zeiss). Optical sections of 1 mm thick,
5686568 pixels (0.1 mm/pixel), were collected sequentially for
each fluorochrome and recorded as eight bit grey levels *.lsm files.
Statistical analysis
We have used a (Wilcoxon-) Mann-Whitney test provided by
GraphPad Prism program to statistically analyze our results. Each
group of deficient mice was compared to wild type mice. We also
compared each group to each other and displayed the result when
it is required. Values of p,0.05 were considered to represent a
significant difference. *, **, *** denote p,0.05, p,0.01, p,0.001,
respectively.
Supporting Information
Figure S1 Characterization of the mCherry-expressing
fluorescent strain of B. melitensis 16M (mCherry-Br). A,
Flow cytometry analysis of B. melitensis 16M and mCherry-Br. B,
Infection of hamster fibroblastic cells BHK with B. melitensis 16M
and mCherry-Br. The LPS of both bacteria is labelled in green
and the mCherry-Br strain appears in red. C, Virulence curve of
B. melitensis 16M and mCherry-Br. Groups of six mice were
inoculated i.p. with 46104 CFU of both Brucella strains. At the
indicated times the CFU per spleen were calculated. Data are
representative of at least 3 independent experiments.
(TIF)
Figure S2 Dynamic of dendritic cell, neutrophil and
macrophage populations in spleen following low and
high doses of bacteria. Wild-type C57BL/6 mice (5 per
groups) were inoculated i.p. with PBS, 46104, 107 CFU or
108 CFU of mCherry-Br, as indicated. At selected time, mice were
sacrificed, spleens were collected and total spleen cells from each
individual mouse were counted by Thoma cell. Cells were
analyzed by flow cytometry, gated according to size and scatter
to exclude dead cells and debris from analysis and then analyzed
for CD11b, CD11c, F4/80, Ly-6C and Ly-6G expression, in order
to obtain the frequencies of dendritic cell, neutrophil and
macrophage subsets, as indicated at the top of each graph. The
total number of each population by spleen was calculated and the
data represent the median +/2 SD of 5 mice. Data are
representative of 2 independent experiments.
(TIF)
Figure S3 Time course of mCherry-Br infection and
number of infected spleen cells by surface unit. A, Wild-
type C57BL/6 and BALB/c mice (6 per groups) were inoculated
i.p. with 108 CFU of mCherry-Br. At the indicated times, CFU
per spleen were calculated. These results are representative of
three independent experiments. B, Graphic representation of the
number of splenic infected cells by surface unit of spleen section at
24 h and 120 h p.i. A unit surface is defined arbitrary as an area of
0,037 mm2, corresponding to the tissue surface examined with
636objective. The bars are the mean 6 SD from at least 3 spleen
sections per spleen from 5 mice.
(TIF)
Figure S4 Co-localization of B. melitensis and Brucella
antigens in vivo. Colocalization analysis of F4/80 expressing
cells, Brucella antigens and mCherry-Br before and 6 h after
mCherry-Br infection in wild-type C57BL/6 mice. Mice were
injected i.p. with PBS or 108 CFU of mCherry-Br. Numbers
indicate the percentage of colocalizing cells in the upper panel.
The inset areas in the middle-right panels are shown in the bottom
panels. Panels are color-coded with the text for the antigen or
mCherry-Br examined. Scale bar = 200 and 50 mm, as indicated.
Data are representative of at least 3 independent experiments. r.p.:
red pulp; w.p.: white pulp; m.z.: marginal zone.
(TIF)
Figure S5 In vivo intracellular localization of Brucella
determined by confocal microscopy. Wild-type C57BL/6
mice were injected i.p. with PBS or 108 CFU of mCherry-Br.
Mice were sacrificed at 1 day p.i. and the spleens were collected
and examined by confocal microscopy. A, Representative confocal
images of spleen section infected with mCherry-Br and labeled
with antibodies against F4/80 (green) antigen. B, Deconvolution
process of a spleen section infected with mCherry-Br and labeled
with antibodies against F4/80 (green) antigen. C, Representative
confocal images of spleen section infected with mCherry-
expressing DvirB B. melitensis mutant and labeled with antibodies
against F4/80 (green) antigen. m, micrometer.
(TIF)
Figure S6 B. melitensis infects LY-6G2/CD11b+ during
the course of infection. Colocalization assay of CD11b, Ly-6G
expressing cells and mCherry-Br, 72 h after infection in wild-type
C57BL/6 mice. Mice were injected i.p. with PBS or 108 CFU of
mCherry-Br. Numbers indicate the percentage of colocalizing cells
in the juxtaposing left panel. Panels are color-coded with the text
for the antigen or mCherry-Br examined. Scale bar = 50 mm, as
indicated. Data are representative of at least 3 independent
experiments. r.p.: red pulp; w.p.: white pulp; m.z.: marginal zone.
(TIF)
Figure S7 Granuloma formation in the spleen of mice
infected by low and high doses of B. melitensis.Wild-type
C57BL/6 mice (5 per groups) were inoculated i.p. with PBS,
46104 or 108 CFU of mCherry-Br, as indicated. At selected time,
mice were sacrificed, spleens were collected and examined by
immunohistofluorescence. Panels are color-coded with the text for
the antigen examined (A), CD11b and (B) F4/80. Scale
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bar = 200 mm, as indicated. r.p.: red pulp; w.p.: white pulp; art.:
central artery. Data are representative of 2 independent
experiments.
(TIF)
Figure S8 B. melitensis infection induces the DC
migration in the spleen during the course of infection.
Positioning of DCs in the spleen of mice before and 12 or 24 h
after mCherry-Br inoculation. Wild-type C57BL/6 mice were
injected i.p. with PBS or 108 CFU of mCherry-Br. Mice were
sacrificed at selected times and spleens were collected and
examined by immunohistofluorescence. Panels are color-coded
with the text for the antigen examined. Scale bar = 200 mm, as
indicated. r.p.: red pulp; w.p.: white pulp; art.: central artery. Data
are representative of at least 3 independent experiments.
(TIF)
Figure S9 B. melitensis infection induces the DC
maturation. Wild type, MyD882/2 and TRIF2/2 C57BL/6
mice were injected i.p. with, 108 CFU of live B. melitenis and
various doses of heat killed (HK) B. melitensis and Escherichia coli
O18:K1. Mice were sacrificed at selected times and spleens were
collected and analyzed by flow cytometry. Cells were gated
according to size and scatter to exclude dead cells and debris from
analysis. A, Spleen cells from individual mice were first analyzed
for Forward Size Scatter (FSC) and CD11c expression. CD11chi
cells in each group were then analyzed for MHC-II and CD86
expression. Number indicates the percentage of positive cells per
106 spleen cells acquired for the specified marker. B, C,
Comparative analysis of CD86 level on CD11chi cells. The data
are the median. Data are representative of at least 3 independent
experiments.
(TIF)
Figure S10 Phenotypical description of Brucella infect-
ed granuloma in the liver. Wild-type C57BL/6 mice were
injected i.p. with PBS or 108 CFU of mCherry-Br. Mice were
sacrificed at 5 days p.i. and livers were collected and examined by
immunohistofluorescence. A, Immunofluorescence analysis of Ly-
6G, CD90, CD11b, CD11c, F4/80, and MHC-II expressing cells
and mCherry-Br. B, Percentage of iNOS+ cells that colocalizes
with CD11b-, and CD11c-expressing cells. Images represent a
single granuloma. Numbers in Figure B indicate the percentage of
colocalizing cells in the upper panel. Panels are color-coded with
the text for the antigen or mCherry-Br examined as well as the
colocalization. Scale bar = 50 mm, as indicated. Data are repre-
sentative of at least 3 independent experiments.
(TIF)
Figure S11 Analysis of the bacterial load of the spleen
and liver in wild type and genetically deficient mice.
Wild-type, IFN-c2/2, IL-12p352/2, MyD882/2 and RAG2/2
C57BL/6 mice and wild-type and IL-12p402/2 BALB/c mice (3–
6 per group) were inoculated i.p. with 108 CFU. 120 h p.i., CFU
per g of spleen (A) and liver (B) were calculated. Data are pooled
from 3 independent experiments displaying similar CFU mean for
wild type mice.
(TIF)
Figure S12 Flow cytometry analysis of iNOS-producing
cells following B. melitensis infection. Wild-type, IFN-c2/
2, IL-12p352/2, MyD882/2 and RAG2/2 C57BL/6 mice and
wild-type and IL-12p402/2 BALB/c mice (3–6 per group) were
inoculated i.p. with 108 CFU of B. melitensis. Mice were sacrificed 5
days post-infection and spleen were collected and analyzed by flow
cytometry. Cells were gated according to size and scatter to
exclude dead cells and debris from analysis. A, Total pooled spleen
cells were first analyzed for Forward Size Scatter (FSC) and iNOS
expression. iNOS+ cells in each group were then analyzed for
CD11b and CD11c expression. Number indicates the percentage
of cells in the selected quadrant. B, Number of CD11b+ CD11c+
iNOS+ cells per 56105 spleen cells acquired. Each data represents
the value obtained from an individual spleen and the data are
pooled from 4 independent experiments.
(TIF)
Figure S13 Kinetic analysis of the bacterial load in the
spleen and liver in wild type and genetically deficient
mice. Wild-type, MyD882/2 and IL-12p352/2 C57BL/6 mice
and wild-type and IL-12p402/2 BALB/c mice (4–8 per group)
were inoculated i.p. with 106 CFU. At 5, 12 and 30 days p.i., CFU
per g of spleen (A) and liver (B) were calculated. Data are
representative from 2 independent experiments.
(TIF)
Figure S14 Localization of B. melitensis during the
course of infection in wild type and Il-12-deficient
BALB/c mice. Wild-type and Il-12p402/2 BALB/c and Il-
12p352/2 C57BL/6 mice were injected i.p. with PBS, 106 CFU
or 108 CFU of mCherry-Br, as indicated. Mice were sacrificed at
12 h, 5 days, 12 days, and 30 days p.i., as indicated. Spleens were
collected and examined by immunohistofluorescence. Positioning
of mCherry-Br in the spleen of Wild-type (A), Il-12p402/2 BALB/
c (B) and Il-12p352/2 C57BL/6 mice (C). Panels are color-coded
with the text for the antigen or mCherry-Br examined. Scale
bar = 200, as indicated. r.p.: red pulp; w.p.: white pulp. Data are
representative of at least 3 independent experiments.
(TIF)
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